Pasithea Therapeutics Corp. (NasdaqCM:KTTA) announces a share repurchase program. Under the program, the company will repurchase up to 5,714,285 common shares for $4 million. The shares will be repurchased at a price of $0.70 per share. The offer will be sourced out of cash on hand. The purpose of the offer is to return capital to stockholders. If the offer is oversubscribed, the company will prorate the number of shares accepted for payment. The offer will expire on September 8, 2023.

James O?Grady of Lowenstein Sandler LLP acted as legal advisor and Broadridge Corporate Issuer Solutions, LLC acted as information agent to the company.